[HTML][HTML] COPD–do the right thing

H Sandelowsky, UM Weinreich, BB Aarli, J Sundh… - BMC family …, 2021 - Springer
A gap exists between guidelines and real-world clinical practice for the management and
treatment of chronic obstructive pulmonary disease (COPD). Although this has narrowed in …

The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD

M Cazzola, M Molimard - Pulmonary pharmacology & therapeutics, 2010 - Elsevier
Bronchodilators are the cornerstone of pharmacological management of COPD. For patients
whose conditions are not sufficiently controlled by monotherapy, combining bronchodilators …

Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomised studies

ER Bleecker, DS Postma, RM Lawrance, DA Meyers… - The Lancet, 2007 - thelancet.com
Background New evidence has suggested that people with asthma who are homozygous for
arginine at aminoacid 16 of the β 2-adrenergic receptor (ADRB2) might not benefit from …

Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases

MS Hussain, P Sharma, DS Dhanjal, N Khurana… - Chemico-biological …, 2021 - Elsevier
Both communicable and non-communicable chronic respiratory conditions have accorded
for suffering of millions of people of all ages and stated to be leading cause of death …

[HTML][HTML] Skeletal muscle in ALS: an unappreciated therapeutic opportunity?

S Scaricamazza, I Salvatori, A Ferri, C Valle - Cells, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the
selective degeneration of upper and lower motor neurons and by the progressive weakness …

[HTML][HTML] Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents

DP Tashkin, LM Fabbri - Respiratory research, 2010 - Springer
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long …

[HTML][HTML] Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease

MT Dransfield, JJ Davis, LB Gerald, WC Bailey - Respiratory medicine, 2006 - Elsevier
BACKGROUND: Although chronic obstructive pulmonary disease (COPD) has been
considered a disease of Caucasian men, recent data show mortality rising faster among …

Airflow obstruction: is it asthma or is it COPD?

P Rogliani, J Ora, E Puxeddu… - International journal of …, 2016 - Taylor & Francis
Despite the availability of guideline recommendations, diagnostic confusion between COPD
and asthma appears common, and often it is very difficult to decide whether the obstruction …

Bronchodilator reversibility in COPD

NA Hanania, BR Celli, JF Donohue, UJ Martin - Chest, 2011 - Elsevier
COPD is a preventable and treatable disease characterized by airflow limitation that is not
fully reversible. The diagnosis of COPD is based on spirometric evidence of airways …

Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome

MO Nakawah, C Hawkins… - The Journal of the …, 2013 - Am Board Family Med
Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic
diseases in the general population. Both are characterized by heterogeneous chronic …